1,024 results on '"Sandset, Per Morten"'
Search Results
2. The breast cancer coagulome in the tumor microenvironment and its role in prognosis and treatment response to chemotherapy
3. Arterial events in cancer patients treated with apixaban for venous thrombosis
4. SARS-CoV-2 vaccines are not associated with hypercoagulability in apparently healthy people
5. Development of a Factor VII Activating Protease (FSAP) generation assay and its application in studying FSAP in venous thrombosis
6. Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays
7. Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolism.
8. Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients – 30 months follow‐up
9. Prevention of post-thrombotic syndrome with rosuvastatin: A multicenter randomized controlled pilot trial (SAVER)
10. Venous thrombosis with oral postmenopausal hormone therapy: Roles of activated protein C resistance and tissue factor pathway inhibitor
11. Editor's Choice – European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis
12. Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism
13. Anticoagulant interventions in hospitalized patients with COVID‐19: A scoping review of randomized controlled trials and call for international collaboration
14. Markers of endothelial cell activation and neutrophil extracellular traps are elevated in immune thrombocytopenia but are not enhanced by thrombopoietin receptor agonists
15. Meeting summary of The NYO3 5th NO-Age/AD meeting and the 1st Norway-UK joint meeting on ageing and dementia: recent progress on the mechanisms and interventional strategies
16. Meeting Summary of The NYO3 5th NO-Age/AD Meeting and the 1st Norway-UK Joint Meeting on Aging and Dementia:Recent Progress on the Mechanisms and Interventional Strategies
17. Tissue factor pathway inhibitor upregulates CXCR7 expression and enhances CXCL12-mediated migration in chronic lymphocytic leukemia
18. Predictors of long-term post-thrombotic syndrome following high proximal deep vein thrombosis: a cross-sectional study
19. Limitations of the Villalta scale in diagnosing post-thrombotic syndrome
20. Effect of hormone replacement therapy on atherogenic lipid profile in postmenopausal women
21. Does the Villalta scale capture the essence of postthrombotic syndrome? A qualitative study of patient experience and expert opinion
22. Meeting summary of The NYO3 5th NO-Age/AD meeting and the 1st Norway-UK joint meeting on ageing and dementia: recent progress on the mechanisms and interventional strategies
23. The impact of post-pulmonary embolism syndrome and its possible determinants
24. Diagnostic scales for the post-thrombotic syndrome
25. Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency
26. Factor VII deficiency: Unveiling the cellular and molecular mechanisms underlying three model alterations of the enzyme catalytic domain
27. Initial strides for invent-VTE: Towards global collaboration to accelerate clinical research in venous thromboembolism
28. Procedure-specific Risks of Thrombosis and Bleeding in Urological Non-cancer Surgery: Systematic Review and Meta-analysis
29. Procedure-specific Risks of Thrombosis and Bleeding in Urological Cancer Surgery: Systematic Review and Meta-analysis
30. Plasminogen, human‐tvmh for the treatment of children and adults with plasminogen deficiency type 1
31. A novel hypoxia response element regulates oxygen-related repression of tissue factor pathway inhibitor in the breast cancer cell line MCF-7
32. Increased expression of TFPI in human carotid stenosis
33. Estrogen induced expression of tissue factor pathway inhibitor-2 in MCF7 cells involves lysine-specific demethylase 1
34. Indirect regulation of TFPI-2 expression by miR-494 in breast cancer cells
35. Normalization of disrupted clock gene expression in males with tetraplegia: a crossover randomized placebo-controlled trial of melatonin supplementation
36. Determinants of acquired activated protein C resistance and D-dimer in breast cancer
37. Functional characterization of annexin A5 gene promoter allelic variants
38. EPAS1/HIF-2 alpha-mediated downregulation of tissue factor pathway inhibitor leads to a pro-thrombotic potential in endothelial cells
39. Polymorphisms of the coagulation system and risk of cancer
40. Women's values and preferences and health state valuations for thromboprophylaxis during pregnancy: A cross-sectional interview study
41. Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial
42. The role of inflammation in post-thrombotic syndrome after pregnancy-related deep vein thrombosis: A population-based, cross-sectional study
43. Outcome Assessment by Central Adjudicators Versus Site Investigators in Stroke Trials: A Systematic Review and Meta-Analysis
44. The effect of the chemical chaperone 4-phenylbutyrate on secretion and activity of the p.Q160R missense variant of coagulation factor FVII
45. Adherence to mechanical thromboprophylaxis after surgery: A systematic review and meta-analysis
46. Theme 4: Invasive management of (recurrent) VTE and PTS
47. Women’s Values and Preferences for Thromboprophylaxis during Pregnancy: A Comparison of Direct-choice and Decision Analysis using Patient Specific Utilities
48. Enhanced thrombin generation and reduced intact protein S in processed solvent detergent plasma
49. Performance and head-to head comparison of three clinical models to predict occurrence of post-thrombotic syndrome. A validation study.
50. “iPSC-derived liver organoids and inherited bleeding disorders: Potential and future perspectives”
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.